Target Name: MIR4281
NCBI ID: G100422962
Review Report on MIR4281 Target / Biomarker Content of Review Report on MIR4281 Target / Biomarker
MIR4281
Other Name(s): microRNA 4281 | hsa-mir-4281 | hsa-miR-4281 | MicroRNA 4281

MIR4281: A Drug Target / Disease Biomarker

MIR4281, also known as ITGB3, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and biology make it an intriguing target for researchers to study, and its potential as a drug have piqued the interest of pharmaceutical companies.

MIR4281 is a small non-coding RNA molecule that is expressed in various tissues and cells throughout the body. It is a member of the ITGB family, which includes several other non-coding RNAs that play important roles in cell signaling and development. One of the most well-known members of this family is ITGB4, which is also known as CD11b and has been shown to play a crucial role in platelet function and blood clotting.

MIR4281 has been shown to play a role in various physiological processes, including cell signaling, migration, and invasion. It has been shown to regulate the activity of several enzymes involved in cell signaling pathways, including the TGF-β pathway, which is involved in cell growth, differentiation, and survival.

MIR4281 has also been shown to be involved in the regulation of gene expression. It has been shown to interact with several proteins, including the transcription factor NF-kappa-B, to regulate the expression of genes involved in various cellular processes, including inflammation, stress response, and cell survival.

In addition to its role in cell signaling and gene regulation, MIR4281 has also been shown to play a potential role as a biomarker for several diseases. Its expression has been shown to be elevated in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that MIR4281 may be a useful biomarker for these diseases and could potentially be used as a target for new therapies.

The potential applications of MIR4281 as a drug target are vast. Its role in cell signaling and gene regulation makes it a potential target for drugs that are designed to modulate these pathways. Its potential as a biomarker for various diseases also makes it an attractive target for drugs that are designed to treat these conditions.

In addition to its potential as a drug target and biomarker, MIR4281 is also of interest to researchers because of its unique structure and biology. Its non-coding nature makes it difficult to study, but its small size and stability make it relatively easy to manipulate. This makes it an attractive target for researchers who are interested in understanding its mechanisms of action and developing new treatments.

Overall, MIR4281 is a non-coding RNA molecule that has the potential to be a drug target and biomarker for various diseases. Its unique structure and biology make it an intriguing target for researchers to study, and its potential as a drug and biomarker are sure to continue to pique the interest of pharmaceutical companies and researchers alike.

Protein Name: MicroRNA 4281

The "MIR4281 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4281 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4282 | MIR4283-1 | MIR4283-2 | MIR4284 | MIR4285 | MIR4286 | MIR4287 | MIR4288 | MIR4289 | MIR429 | MIR4290 | MIR4291 | MIR4292 | MIR4293 | MIR4294 | MIR4295 | MIR4296 | MIR4297 | MIR4298 | MIR4299 | MIR4300 | MIR4300HG | MIR4301 | MIR4302 | MIR4303 | MIR4304 | MIR4305 | MIR4306 | MIR4307 | MIR4308 | MIR4309 | MIR431 | MIR4310 | MIR4311 | MIR4312 | MIR4313 | MIR4314 | MIR4315-1 | MIR4315-2 | MIR4316 | MIR4317 | MIR4318 | MIR4319 | MIR432 | MIR4320 | MIR4321 | MIR4322 | MIR4323 | MIR4324 | MIR4325 | MIR4326 | MIR4327 | MIR4328 | MIR4329 | MIR433 | MIR4330 | MIR4418 | MIR4420 | MIR4423 | MIR4425 | MIR4427 | MIR4428 | MIR4429 | MIR4430 | MIR4431 | MIR4432 | MIR4432HG | MIR4433A | MIR4433B | MIR4435-1 | MIR4435-2 | MIR4435-2HG | MIR4436A | MIR4436B1 | MIR4436B2 | MIR4437 | MIR4440 | MIR4441 | MIR4442 | MIR4443 | MIR4444-1 | MIR4444-2 | MIR4445 | MIR4446 | MIR4447 | MIR4448 | MIR4449 | MIR4450 | MIR4451 | MIR4453 | MIR4453HG | MIR4454 | MIR4455 | MIR4456 | MIR4457 | MIR4458 | MIR4458HG | MIR4463 | MIR4465 | MIR4466